Women’s health and neuroscience research programme

The overall research programme focuses on women, women’s health, fertility, brain, nutrition, neuroendocrine and female athlete optimisation. We want to investigate the intricate relationship between hormones and concussion outcomes, which is essential for developing targeted interventions and improving the wellbeing of females, who may experience unique hormonal responses after concussions. There will be a number of studies in the women’s health and neuroscience (WHN) research programme.

Women’s Health and Neuroscience research programme

Participant recruitment

WHN-Study-1-Recovery

We're looking for female and male participants 16 years or older who have experienced a RECENT (i.e., within seven months of joining the study) mild to moderate traumatic brain injury (mTBI). To join the mTBI group, individuals must be evaluated by a qualified healthcare professional who believes they have likely suffered an mTBI.

We are also looking for female and male participants 16 years or older to be in the Healthy control group. If you have NOT had a mTBI within the last 12 months or are NOT experiencing lingering symptoms from a previous mTBI, you can be in the healthy control group.

Interested individuals can read the Participant Information Sheet to ensure you meet the inclusion criteria (stated below), and then provide informed consent by filling in the consent form (download and open in word) and mailing to the research team via brain@aut.ac.nz. You can then book an assessment time.

Read frequently asked questions for interested participants

For all participant enquiries email brain@aut.ac.nz or call 021 968 731.

What to expect during the evaluation

WHN-Study-2-BrainWOF

We will be recruiting people with both high and low levels of exposure to head impacts. We are looking for:

  1. Sports players, and people who have experienced domestic violence or served in the military.
  2. Aged between 25 and 70 years.
  3. Currently resident in NZ.

BrainWOF protocol infographic

Interested individuals can read the Participant Information Sheet to ensure you meet the inclusion criteria, and then provide informed consent by filling in the consent form (download and open in word) and mailing to the research team via brain@aut.ac.nz. You can then book an assessment time.

Women’s health and neuroscience research projects in progress

For details please click on the project titles below.

The study hopes to improve how we detect and manage mild traumatic brain injuries (mTBI) using blood tests for females and males.

We aim to understand whether biomarkers (I.e., GFAP and UCH-L1) can assist in monitoring mTBI recovery in females and males. The main study questions are:

  1. What are the optimal sampling times for blood biomarkers to determine the prediction of recovery from mTBI for females and males?
  2. What is the feasibility of blood biomarker data collection in the NZ environment?
  3. What are the effects of confounding factors (i.e., sex, age, ethnicity) on mTBI blood biomarkers in a patients with mTBI?

Concussion Blood Sampling (CBS)

Participant recruitment

We're looking for female and male participants 16 years or older who have experienced a RECENT (i.e., within seven months of joining the study) mild to moderate traumatic brain injury (mTBI). To join the mTBI group, individuals must be evaluated by a qualified healthcare professional who believes they have likely suffered an mTBI.

We are also looking for female and male participants 16 years or older to be in the Healthy control group. If you have NOT had a mTBI within the last 12 months or are NOT experiencing lingering symptoms from a previous mTBI, you can be in the healthy control group.

Interested individuals can read the Participant Information Sheet to ensure you meet the inclusion criteria, and then provide informed consent by filling in the consent form (download and open in word) and mailing to the research team via brain@aut.ac.nz. You can then book an assessment time.

Read frequently asked questions for interested participants

For all participant enquiries email brain@aut.ac.nz or call 021 968 731.

What to expect during the evaluation

Who can take part in the study?

You have been invited to take part in this study because you are aged 16 years and older and are either healthy or have recently suffered a mild traumatic brain injury (mTBI). You will be able to start the study if you meet the inclusion criteria outlined below.

To take part in the study you need to be aged 16 or older, reside in New Zealand, be able to provide informed consent, able to provide a blood sample and (for the mTBI group) have sustained a recent mTBI/concussion.

You can NOT take part in the study is you have a suspected or confirmed neurodegenerative conditions or dementia, including, but not limited to, dementia (Alzheimer’s disease, and vascular, Lewy body, or frontotemporal dementia), Parkinson’s, Huntington’s, motor neurone disease and mild cognitive impairment, and no history of acute neurological events or structural brain abnormalities including TBI, stroke, seizure, epilepsy, chronic headache, and brain tumour and no unstable severe medical conditions for example; cancer, severe coagulopathy, terminal illness, end-stage organ failure, acute kidney dysfunction, chronic kidney dysfunction or renal failure.

If you are a control, you can NOT take part in this study if you have experienced a mTBI within the last 12 months or are experiencing lingering symptoms from a previous mTBI.

Posters for study

Posters for study

Quick facts

Study acronym: Concussion Blood Sampling (CBS)
Study period: Feb 2025 to Dec 2025
HDEC ethics: HDEC #2024 EXP 21888. 2024-2027.  (Approved 14th March 2024 for three years.)
AUTEC ethics: AUTEC 25/138. Approved 1st May 2025 for three years.
Clinical trial registration number: ACTRN12625000260426. Approved 9th April 2025 for three years.

Further information

Research team members

Co-ordinating Principle Investigator: Professor Patria Hume

Co-Principle Investigators: Dr Ed Maunder, Scott Crawford, Dr Doug King, Dr Beth McQuiston, Dr Chris Puliu’vea, Dr Stephen Kara, Professor Alice Theadom, Assoc Prof Mangor Pedersen, Dr Anja Zoellner.

Co-Associate Investigators: Dr Ryu Yoshida, Dr Helen Danesh-Myer, Dr Mark Fulcher, Dr Swati Pradhan-Bhatt, Katherine Forch, Dr Trevor Clark, Dr Sapi Mukerji, Prof Andrew Kilding, Dr Danielle Yang, Dr Sharon Olsen, Dr Stacy Sims, Dr Brian Russell, Dr Ken Quarrie, Christina Emmerson, Dr Christi Essex, Dr Kuniaki Hirayama, Marguerite Sandleback.

Research students: Nikki Reynolds, Charlotte Bray.

Māori research team members: Dr Doug King (Ngāi Tūhaitara, Ngāi Tūhu), Dr Trevor Clark (Tainui, Ngaati Korokii Kahukura), Dr Stephen Kara.

Pasifica research team members: Dr Chris Puliu’vea, Assoc Prof Mangor Pedersen.

The Problem

This study addresses growing concerns in the community about the long-term impact of repeated concussions/head impacts on brain health, particularly the risk of developing cognitive impairment or dementia later in life. The size of the problem remains unknown and how relative risk of head impacts to other known brain health risk factors, the protective factors and if biomarkers can predict long-term cognitive changes which would help identify people at risk are unclear.

BrainWOF protocol infographic

Aims

  • To identify the size of the problem (e.g., what proportion of people who are concerned about their brain health after exposure to repeated head impacts are experiencing cognitive difficulties after controlling for age and sex?).
  • To identify relevant risk factors (e.g., do the 14 modifiable brain health risk factors identified as predictive of dementia in the general population apply to people who have been exposed to repeated head impacts?)
  • To identify the relative importance of repeated head impacts in relation to the other 13 brain health risk factors. This work will enable us to develop proactive detection and prevention strategies to reduce the risk and slow the decline of early cognitive impairment and neurodegenerative brain disease for people at risk.

Participant recruitment

Inclusion criteria:

We will be recruiting people with both high and low levels of exposure to head impacts. We are looking for:

  1. Sports players, and people who have experienced domestic violence or served in the military.
  2. Aged between 25 and 70 years.
  3. Currently resident in NZ.

Exclusion criteria:

  1. A severe (life threatening) or unstable medical condition e.g., cancer, psychiatric disorder, cancer, severe coagulopathy, terminal illness, end-stage organ failure, or renal failure.
  2. Unable to provide consent due to cognitive impairment or language barriers.
  3. Have been diagnosed with a cognitive condition such as learning disability, dementia or Alzheimer’s disease.
  4. Individuals with a history of acute neurological events or structural brain abnormalities including, but not limited to, severe TBI, seizure, epilepsy, stroke, or brain tumour, Parkinson’s disease, Huntington’s disease, and motor neurone disease.
  5. Unable to hold and use a pencil to complete the cognitive tests.

Interested individuals can read the Participant Information Sheet to ensure you meet the inclusion criteria, and then provide informed consent by filling in the consent form (download and open in word) and mailing to the research team via brain@aut.ac.nz. You can then book an assessment time.

For all participant enquiries email brain@aut.ac.nz or call 021 968 731.

Quick facts

Study acronym: Brain-WOF
Study period: June 2026 to June 2027
HDEC ethics: HDEC #2026 EXP 21888. 2026-2029.  (Approved 5th May 2026 for three years.)

Further information

Research team members

Co-Principle Investigators: Professor Patria Hume and Professor Alice Theadom

Co-Associate Investigators: Dr Josh McGeown, Dr Helen Murray, Dr Beth McQuiston, Dr Natalie Hardaker, Dr Jason Chua, Dr Ed Maunder, Dr Chris Puliu’vea, Adjunct Professor Doug King, Dr Ken Quarrie, Dr Josh Faulkner, Dr Scott Crawford, Dr Sam Guy, Dr Nusratnaaz Shaikh, Dr Tina Gao, Professor Helen Pilmore.

Community Research Collaborators: Manu Albert (Ngāti Porou), David Rayner, Sharon Kearney, Shawn Stewart (Tainui, Te Ati Awa, and Maniapoto), Ani Cherrington, George Jahnke (Ngati Tuwharetoa, Ngati Porou), Matt Hawkins, Shontayne Hape.

Research Staff: Marguerite Sandleback, Danastri Ramadhani, Nikki Reynolds, Julia Parry, Jordan Boriel, Elena Prandoni, Louise Ramari Ashby (Te Rarawa, Te Aupōuri), Research officers to be appointed. Postgraduate students to be appointed.

Abbott advisory research staff: Dr Liza Kunz, Dr Randal Schneider, Dr Raj Chandran, Dr Martin Berman.

Māori research team members: Dr Doug King (Ngāi Tūhaitara, Ngāi Tūhu), Dr Trevor Clark (Tainui, Ngaati Korokii Kahukura), Louise Ramari Ashby (Te Rarawa, Te Aupōuri), Manu Albert (Ngāti Porou), Shawn Stewart (Tainui, Te Ati Awa, and Maniapoto), Ani Cherrington, George Jahnke (Ngati Tuwharetoa, Ngati Porou), Shontayne Hape, Sam Guy (Ngāti Maru).

Postgraduate student researchers who may use data for their theses: Nikki Reynolds, Louise Ramari Ashby (Te Rarawa, Te Aupōuri).

Data collection complete - results will be available soon

Physical Evolution through Pregnancy

We are currently recruiting for this project.

Recruitment flyer

Project team

  • Jie Chen
  • Julie Choisne
  • Patria Hume
  • Hannah Wyatt.

UoA Ethics AH27603 approved to 27/11/2027

For further information contact: Jie Chen jie.chen@aut.ac.nz

The purpose of this study is to investigate the relationship between salivary hormone profiles and symptoms across the menstrual cycle as monitored by a menstrual cycle tracking app (WILD AI) in healthy eumenorrheic (naturally regularly menstruating) females. The hormones included in the salivary measures will be estrogen, progesterone and cortisol. The second part of this study is to confirm salivary measures of estrogen and progesterone against blood serum.

Estrogen and progesterone, the primary female sex hormones, are typically associated with reproduction and are linked to brain health. Cortisol is the primary stress hormone, and levels of cortisol can influence female sex hormones.

Knowledge gained from this study about how salivary hormone profiles change in relation to symptoms throughout the menstrual cycle will be used to inform a related study that will investigate symptoms in females recovering from sports-related concussion.

(AUTEC 21/167 valid to 9 July 2024)

Data collection complete - results will be available soon

The purpose of this study is to increase our understanding of how the female sex hormones influence the symptomology and time to recover from concussion/mTBI (from all environments) in general population females. This study also considers whether energy availability may be a modifier in the symptomology and time to recover from concussion/mTBI in females.

This knowledge will help direct future research and inform clinical decision making for doctors and other members of the multidisciplinary team during treatment and rehabilitation of females with concussion/mTBI.

Participants

This study is now recruiting females of reproductive age presenting to Emergency Departments in Wellington with a suspected concussion. The study aims to understand the how hormone profiles at point of injury may impact on time to recovery. A secondary aim of the study is to investigate the expression of salivary miRNAs in females with concussion and whether this is influenced by hormone profile.

Principal investigator: Natalie Hardaker

(HDEC EXP 11655)

This study will examine the current level of knowledge around recognising concussion and the attitudes towards concussion (what players and coaches would do if they suspected a concussion). The study will target as many amateur football players and coaches from around the world as possible and will also examine if there is a difference in these two domains (knowledge and attitudes) between females and males.

Findings from this study will highlight areas to target education to address knowledge deficiencies and unsafe attitudes towards concussion. A greater understanding of how players and coaches perceive concussion will help direct how we can support players to stay in the game and protect long term health. The results of this study can also be used as a baseline against which the effectiveness of any interventions used to improve knowledge and attitudes around concussion can be measured.

The Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS) will be made available online and takes approximately 10 minutes to complete. The study will be promoted through social media channels (facebook and twitter), email databases and via posters advertising the study in football club rooms (in NZ only).

Data collection complete - results will be available soon

Principal investigator: Natalie Hardaker

(AUTEC Reference number 22/192 valid until 23 August 2025)

A prospective observational pilot case study was conducted between 1 October 2025 and 15 March 2026 by Master’s thesis student Sarniya Moganathas with co-supervisors Prof Patria Hume, Dr Naaz Shaikh and Dr Anja Zoellner. The study included 10 healthy female participants with no history of concussion or musculoskeletal injury, who attended multiple study visits (up to 12 sessions) over a three-month period. Participants completed questionnaires, performed single-task, dual-task, and head-turn walking assessments, and provided blood samples for hormonal analysis. Significant hormonal variations occurred across menstrual phases, particularly in oestradiol, progesterone, luteinising hormone, follicle-stimulating hormone, testosterone, thyroid-stimulating hormone, and dehydroepiandrosterone. However, no significant differences were identified in gait parameters across menstrual phases, with gait performance remaining stable despite hormonal fluctuations.

Quick facts

Study acronym: WHIP
Study period: 26 Aug 2025 to 26 Aug 2028
HDEC ethics: HDEC #2024 EXP 21888
AUTEC ethics: 25/152

The purpose of this study is to understand how sex hormones may influence the occurrence of and recovery from sports related concussion (SRC) in female athletes. This study will also consider whether the female sex hormones influence biomarkers specifically related to concussion.

This knowledge will help direct future research and inform the development of female specific prevention and recovery protocols for female athletes with SRC.

Participants

The study is prospectively investigating a cohort of eumenorrheic athletes from sports with a high risk of SRC including; Football (soccer), League, Rugby and Netball in New Zealand. The athletes will be recruited into 3 groups:

  1. SRC group - athletes that sustain an SRC during the season;
  2. Control group - age matched athletes that do not sustain an SRC or any other musculoskeletal injury;
  3. SubConc group - athletes (four per match) recruited at random by the research team to undergo repeat baseline concussion testing

Data collection complete - results will be available soon

Principal investigator: Natalie Hardaker

(HDEC EXP 11904)

Research outputs

Female specific or sex differences research

Other research

Upcoming

  • O'Loughlin, E., Reid, D., & Sim, S. (2022, October). Using focus groups to design and evaluate a rehabilitation programme for women post-anterior cruciate ligament reconstruction. Sports Medicine New Zealand Annual Conference. Wellington, New Zealand: Sports Medicine New Zealand.
  • George, E., Reid, D., & Sheerin, K. (2022, October). Title to be confirmed. Sports Medicine New Zealand Annual Conference. Wellington, New Zealand: Sports Medicine New Zealand.

Past

  • O'Loughlin, E., Reid, D., & Sim, S. (2022, May). Discussing the menstrual cycle in the sports medicine clinic: Perspectives of orthopaedic surgeons, physiotherapists, athletes, and patients. Verbal presentation at the British Association of Sport and Exercise Medicine (BASEM) Conference: Positive Health & Performance, Brighton, UK.

Radio interviews

Podcasts

Watch Dr Christi Essex and WHN participant Luke Wolfkamp's interview on 7 Sharp, discussing the experience of concussion and the importance of this blood biomarker programme.

Watch Professor Patria Hume's interview on 7 Sharp with Hillary Barry and Jeremy Wells, discussing concussion risks, symptoms, and our groundbreaking blood biomarker programme.

We conduct research projects to help improve women’s health with focus on brain health using:

  • Brain health screening - Brain-WOF™
  • Brain injury screening - BIST™
  • Blood biomarkers for brain, hormones, health
  • Menstrual cycle tracking
  • Eye tracking
  • Brain scanning
  • Balance testing
  • Psychology assessments
  • Physiology assessments
  • Biomechanics assessments
  • Body composition assessments

Practical guidelines and resources

Industry Partners

abbott-logo_.jpg
wild-ai-logo.jpg

Contact us

Auckland location

Scott Crawford
Research Operations Senior Manager
brain@aut.ac.nz
021 968 731

Nikki Reynolds
Women's Health and Neuroscience PhD Student
brain@aut.ac.nz
021 968 731

Marguerite Sandleback
Women's Health and Neuroscience Research Officer
brain@aut.ac.nz
021 968 731

Hutt Valley (Wellington) location

Research Nurses
researchHVED@gmail.com

Our team

This research programme has been co-created with iwi, interdisciplinary researchers and people from various backgrounds and ethnicities.

Meet the team

Te Kukunetanga: Developing Cycle of Life Research Programme

Te Kukunetanga is a series of projects aiming to improve the pregnancy journey and outcomes for wahine and their whanau.

Find out more

Brain Health Clinic and research programme

The AUT Brain Health research programme is a collaboration between SPRINZ and the Traumatic Brain Injury Network (TBIN). We focus on how to prevent, identify and treat traumatic brain injuries (TBIs), with the aim of working towards better health and wellbeing for people affected by TBI.

Find out more

Study with us

We are keen to collaborate with postgrad students who want to study how to improve health outcomes for women at master’s or doctoral level. Our supervisors are experienced in a range of fields.

Find out more